These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 564343)

  • 1. Primary structure of bovine plasma high-molecular-weight kininogen. Characterization of carbohydrate-free fragment 1.2 (fragment X) released by the action of plasma kallikrein and its biological activity.
    Han YN; Kato H; Iwanaga S; Oh-Ishi S; Katori M
    J Biochem; 1978 Jan; 83(1):213-21. PubMed ID: 564343
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary structure of bovine high molecular weight kininogen: chemical compositions of kinin-free kininogen and peptide fragments released by plasma kallikrein.
    Han YN; Komiya M; Kato H; Iwanaga S; Suzuki T
    FEBS Lett; 1975 Oct; 57(3):254-8. PubMed ID: 1181197
    [No Abstract]   [Full Text] [Related]  

  • 3. Bovine plasma high molecular weight kininogen: the amino acid sequence of fragment 1 (glycopeptide) released by the action of plasma kallikrein and its location in the precursor protein.
    Han YN; Kato H; Iwanaga S; Suzuki T
    FEBS Lett; 1976 Mar; 63(1):197-200. PubMed ID: 1261681
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on human kininogens. I. Isolation, characterization, and cleavage by plasma kallikrein of high molecular weight (HMW)-kininogen.
    Nakayasu T; Nagasawa S
    J Biochem; 1979 Jan; 85(1):249-58. PubMed ID: 104988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High molecular weight kininogen: its inability to correct the clotting of kininogen-deficient plasma after cleavage of bradykinin by plasma kallikrein, plasmin or trypsin.
    Chan JY; Movat HZ; Burrowes CE
    Thromb Res; 1979; 14(6):817-24. PubMed ID: 157559
    [No Abstract]   [Full Text] [Related]  

  • 6. Actions of urinary kallikrein, plasmin, and other kininogenases on bovine plasma high-molecular-weight kininogen.
    Han YN; Kato H; Iwanaga S; Komiya M
    J Biochem; 1978 Jan; 83(1):223-35. PubMed ID: 146707
    [No Abstract]   [Full Text] [Related]  

  • 7. Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen.
    Matheson RT; Miller DR; Lacombe MJ; Han YN; Iwanaga S; Kato H; wuepper KD
    J Clin Invest; 1976 Dec; 58(6):1395-406. PubMed ID: 993350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the primary structure of bovine high-molecular-weight kininogen. Amino acid sequence of a fragment ("histidine-rich peptide") released by plasma kallikrein.
    Han YN; Komiya M; Iwanaga S; Suzuki T
    J Biochem; 1975 Jan; 77(1?):55-68. PubMed ID: 1169237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The carbohydrate structure of a glycopeptide released by the action of plasma kallikrein on bovine plasma high-molecular-weight kininogen.
    Endo Y; Yamashita K; Han YN; Iwanaga S; Kobata A
    J Biochem; 1977 Aug; 82(2):545-50. PubMed ID: 914796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible physiological role of new peptide fragments released from bovine high molecular weight kininogen by plasma kallikrein.
    Oh-ishi S; Katori M; Nam Han Y; Iwanaga S; Kato H
    Biochem Pharmacol; 1977 Jan; 26(2):115-20. PubMed ID: 138423
    [No Abstract]   [Full Text] [Related]  

  • 11. The accelerating effect of bovine plasma HMW kininogen on the surface-mediated activation of factor XII: generation of a derivative form (active kininogen) with maximal cofactor activity by limited proteolysis.
    Sugo T; Kato H; Iwanaga S; Fujii S
    Thromb Res; 1981 Nov; 24(4):329-37. PubMed ID: 6917562
    [No Abstract]   [Full Text] [Related]  

  • 12. [On "contact activation inhibitors" released from bovine plasma high molecular weight kininogen by plasma kallikrein (author's transl)].
    Iwanaga S; Kato H; Ham YN; Oh-Ishi S; Katori M
    Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):575-8. PubMed ID: 567922
    [No Abstract]   [Full Text] [Related]  

  • 13. Rat plasma high-molecular-weight kininogen. A simple method for purification and its characterization.
    Hayashi I; Kato H; Iwanaga S; Oh-ishi S
    J Biol Chem; 1985 May; 260(10):6115-23. PubMed ID: 3846594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage of human high molecular weight kininogen by human plasma kallikrein.
    Nagasawa S; Nakayasu T
    Adv Exp Med Biol; 1979; 120B():163-71. PubMed ID: 517233
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of HMW kininogen in surface-mediated activation of Factor XII.
    Shimada T; Sugo T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():73-85. PubMed ID: 6134440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine Hageman factor and its fragments.
    Fujikawa K
    Methods Enzymol; 1988; 163():54-68. PubMed ID: 3237089
    [No Abstract]   [Full Text] [Related]  

  • 18. Binding and dissociation of Hageman factor, prekallikrein and high molecular weight kininogen in human plasma during contact activation.
    Nakahara M
    Biochem Pharmacol; 1980 May; 29(9):1247-54. PubMed ID: 6772195
    [No Abstract]   [Full Text] [Related]  

  • 19. Activation of surface-bound Hageman factor: pre-eminent role of high molecular weight kininogen and evidence for a new factor.
    Webster ME; Guimaraes JA; Kaplan AP; Colman RW; Pierce JV
    Adv Exp Med Biol; 1976; 70(00):285-99. PubMed ID: 937135
    [No Abstract]   [Full Text] [Related]  

  • 20. Bovine plasma HMW and LMW kininogens. Structural differences between heavy and light chains derived from the kinin-free proteins.
    Kato H; Han YN; Iwanaga S; Suzuki T; Komiya M
    J Biochem; 1976 Dec; 80(6):1299-311. PubMed ID: 1035217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.